Biogen's lecanemab receives FDA Breakthrough Therapy Designation in the United States
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, January 28｜Biogen's Litifilimab has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the treatment of cutaneous lupus erythematosus, a disease that currently has no targeted therapies.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
September New York Fed Services Index Falls More Than Expected
MT newswire•2026/09/16 12:38
Precore Gold Finishes Magnetic Survey at its Arikepay Gold Project
MT newswire•2026/09/16 12:37
Surge Copper Begins Environmental Assessment Process for Berg Copper Project
MT newswire•2026/09/16 12:36
Electra Battery Materials Gets Preliminary Engineering Results for Initial Phase of Proposed Nickel Refinery
MT newswire•2026/09/16 12:32
Crypto prices
More
Bitcoin
BTC
$75,894.24
-1.30%
Ethereum
ETH
$2,406.36
-2.82%
Tether USDt
USDT
$0.9991
-0.05%
BNB
BNB
$712.54
-0.86%
XRP
XRP
$1.28
-8.82%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$97.41
-3.49%
TRON
TRX
$0.3347
-1.06%
Zcash
ZEC
$1,213.61
+7.57%
Hyperliquid
HYPE
$78.5
-0.96%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now